内幕交易公司股票 南卫股份实控人及财务总监拟被罚没近5000万

Core Viewpoint - The announcement reveals that the controlling shareholder and the financial director of Nanwei Co., Ltd. are facing administrative penalties for insider trading, with significant amounts of illegal gains and fines involved [1][3]. Group 1: Insider Trading Case - The controlling shareholder Li Ping is proposed to have illegal gains of 11.77 million yuan and a fine of 35.33 million yuan for insider trading [1]. - The financial director Xiang Qinhua is proposed to have illegal gains of 101,700 yuan and a fine of 1.5 million yuan for insider trading [1]. - The total illegal gains to be confiscated from both individuals amount to 11.88 million yuan, with total fines proposed at 36.83 million yuan [1]. Group 2: Audit and Financial Reporting Issues - The audit by Tianheng Accounting Firm began on November 10, 2022, and revealed issues with fund misappropriation and unreturned loans [2]. - The audit team identified discrepancies in the construction project accounts and requested supporting materials, which the company failed to provide [2]. - As a result of the audit findings, Tianheng issued a negative opinion on the internal control report for 2022, leading to significant market impacts, including stock suspension [2]. Group 3: Company Overview and Financial Forecast - Nanwei Co., Ltd. was established in 1990 and specializes in the research, production, and sales of medical products, including transdermal products and protective gear [3]. - The company anticipates a net profit loss of between 16 million yuan and 12 million yuan for the first half of 2025, with a non-recurring net profit loss expected between 18 million yuan and 14 million yuan [3].